Project Details
Description
A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 3 Study with Open-label Period to Evaluate the Efficacy and Safety of Inebilizumab in Adults with Myasthenia Gravis
| Status | Active |
|---|---|
| Effective start/end date | 1/1/21 → 12/31/24 |
Funding
- MEDPACE, INC.
- VIELA BIO, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.